Your browser is no longer supported. Please, upgrade your browser.
Settings
GNMK GenMark Diagnostics, Inc. daily Stock Chart
GNMK [NASD]
GenMark Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.73 Insider Own4.70% Shs Outstand60.67M Perf Week-8.48%
Market Cap1.15B Forward P/E- EPS next Y-0.26 Insider Trans-3.36% Shs Float58.17M Perf Month-13.04%
Income-42.30M PEG- EPS next Q-0.09 Inst Own75.90% Short Float10.77% Perf Quarter27.73%
Sales105.20M P/S10.90 EPS this Y9.40% Inst Trans0.51% Short Ratio3.01 Perf Half Y210.02%
Book/sh0.21 P/B78.10 EPS next Y38.10% ROA-42.80% Target Price19.25 Perf Year146.99%
Cash/sh0.67 P/C24.34 EPS next 5Y- ROE-348.60% 52W Range3.36 - 20.88 Perf YTD240.96%
Dividend- P/FCF- EPS past 5Y2.30% ROI-51.50% 52W High-21.46% Beta3.08
Dividend %- Quick Ratio2.80 Sales past 5Y23.50% Gross Margin37.00% 52W Low388.10% ATR1.41
Employees437 Current Ratio3.20 Sales Q/Q80.00% Oper. Margin-34.20% RSI (14)49.05 Volatility11.05% 7.43%
OptionableYes Debt/Eq5.35 EPS Q/Q45.90% Profit Margin-40.20% Rel Volume1.15 Prev Close19.06
ShortableYes LT Debt/Eq5.09 EarningsAug 04 AMC Payout- Avg Volume2.08M Price16.40
Recom1.90 SMA20-8.41% SMA5013.57% SMA20099.55% Volume2,416,128 Change-13.96%
Aug-05-20Reiterated Needham Buy $19 → $22
Jul-08-20Reiterated Needham Buy $15 → $19
May-05-20Reiterated Needham Buy $11 → $15
Feb-11-20Downgrade Raymond James Outperform → Mkt Perform
Dec-11-19Downgrade JP Morgan Overweight → Neutral
Feb-22-19Reiterated Needham Buy $12
Nov-03-17Reiterated Needham Buy $15 → $11
Nov-03-17Downgrade Raymond James Outperform → Mkt Perform
Sep-18-17Initiated BofA/Merrill Buy $13
Sep-13-17Reiterated Needham Buy $17 → $15
Aug-31-17Resumed BTIG Research Buy $13
Jun-13-17Reiterated Needham Buy $16 → $17
Jan-24-17Reiterated Needham Buy $13 → $15
Feb-24-16Reiterated Needham Buy $13 → $11
Oct-28-15Reiterated Needham Buy $16 → $13
May-06-15Reiterated Canaccord Genuity Buy $16 → $14
Apr-17-15Reiterated Canaccord Genuity Buy $17 → $16
Dec-19-13Initiated Needham Buy $17
Aug-08-13Reiterated Canaccord Genuity Buy $18 → $14
Apr-15-13Reiterated Canaccord Genuity Buy $14 → $18
Aug-05-20 02:01AM  
Aug-04-20 05:20PM  
04:05PM  
Jul-29-20 04:05PM  
Jul-24-20 10:15AM  
Jul-22-20 12:22PM  
11:30AM  
Jul-21-20 04:05PM  
04:05PM  
Jul-14-20 06:56AM  
Jul-09-20 09:54PM  
Jul-08-20 04:18PM  
12:07PM  
07:31AM  
04:55AM  
Jul-07-20 04:05PM  
Jun-29-20 07:00AM  
Jun-28-20 04:07PM  
Jun-27-20 01:15PM  
Jun-19-20 12:16PM  
12:00PM  
Jun-16-20 08:00AM  
Jun-12-20 07:55PM  
Jun-10-20 08:35AM  
08:29AM  
May-28-20 10:30AM  
May-27-20 04:05PM  
May-26-20 08:49AM  
May-14-20 11:16AM  
May-11-20 04:01PM  
May-08-20 10:52AM  
May-07-20 10:39AM  
May-06-20 10:59PM  
04:01PM  
May-05-20 08:00AM  
04:01AM  
May-04-20 06:55PM  
04:05PM  
04:03PM  
Apr-27-20 12:31PM  
Apr-24-20 10:50AM  
Apr-23-20 10:01AM  
Apr-22-20 04:05PM  
Apr-20-20 07:54AM  
Apr-08-20 04:26PM  
07:53AM  
02:45AM  
Apr-07-20 04:03PM  
Mar-23-20 07:45PM  
09:31AM  
09:30AM  
Mar-22-20 08:19AM  
Mar-19-20 09:23PM  
Mar-11-20 12:47PM  
10:44AM  
10:18AM  
09:54AM  
09:06AM  
08:26AM  
08:00AM  
Mar-04-20 08:04AM  
Mar-02-20 05:35PM  
04:05PM  
04:03PM  
Feb-25-20 08:35AM  
Feb-24-20 12:30PM  
09:28AM  
Feb-18-20 04:05PM  
Feb-17-20 05:57AM  
Feb-10-20 05:30PM  
05:15PM  
Jan-13-20 07:00AM  
Jan-06-20 07:25AM  
Jan-01-20 12:14PM  
Dec-31-19 07:57AM  
Dec-30-19 04:05PM  
Dec-12-19 09:07PM  
07:38PM  
Nov-13-19 04:05PM  
Nov-07-19 07:22AM  
Nov-06-19 06:45PM  
04:03PM  
Nov-01-19 12:15PM  
Oct-30-19 10:34AM  
Oct-23-19 04:05PM  
Oct-12-19 10:47AM  
Sep-16-19 09:12AM  
Aug-30-19 02:20AM  
Aug-19-19 11:08AM  
Aug-05-19 09:23PM  
07:25PM  
04:05PM  
Jul-29-19 10:34AM  
Jul-25-19 04:05PM  
Jul-22-19 04:05PM  
10:31AM  
Jul-19-19 02:34PM  
Jul-05-19 12:25PM  
May-28-19 07:52PM  
May-23-19 04:05PM  
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 04Sale18.932083,937175,775Aug 05 07:25 PM
Mitchell Brian AndrewSVP, OperationsAug 04Sale18.9362111,756226,187Aug 05 07:23 PM
Mitchell Brian AndrewSVP, OperationsAug 03Sale17.924,00071,680226,808Aug 03 06:39 PM
Jensen TylerSVP, Engineering and Tech DevJul 28Sale17.302123,668214,160Jul 29 07:09 PM
Harkins Michael JohnSVP, SalesJul 28Sale17.301,05218,200131,074Jul 29 07:03 PM
Winkler Sarah HollisVP, Human ResourcesJul 28Sale17.3073712,750126,274Jul 29 07:01 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesJul 28Sale17.301702,941175,983Jul 29 06:59 PM
Mitchell Brian AndrewSVP, OperationsJul 01Sale14.454,00057,800230,808Jul 02 06:28 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesJun 08Sale9.147807,129176,153Jun 09 05:37 PM
Mitchell Brian AndrewSVP, OperationsJun 01Sale9.724,00038,880234,808Jun 02 06:04 PM
Mitchell Brian AndrewSVP, OperationsMay 28Sale9.522,02119,240238,808Jun 01 05:19 PM
Ek John FrederickChief Financial OfficerMay 28Sale9.521,46013,899265,741Jun 01 05:15 PM
Jensen TylerSVP, Engineering and Tech DevMay 28Sale9.521,16811,119214,372Jun 01 05:13 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsMay 28Sale9.522,06619,668265,564Jun 01 05:11 PM
Mendel ScottPresident & CEOMay 28Sale9.523,75135,710447,328Jun 01 05:08 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesMay 28Sale9.521,17911,224176,933Jun 01 05:05 PM
Stier EricSVP & General CounselMay 28Sale9.522,60224,771297,687Jun 01 05:03 PM
Gleeson MichaelSVP, Corp. AccountsMay 28Sale9.522,81526,799433,127Jun 01 04:59 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffaiirsMay 19Sale10.461,31913,797267,630May 20 06:12 PM
Mitchell Brian AndrewSVP, OperationsMay 19Sale10.462,13122,290240,829May 20 06:10 PM
Jensen TylerSVP, Engineering and Tech DevMay 19Sale10.461,15412,071215,540May 20 06:06 PM
Mendel ScottPresident & CEOMay 19Sale10.462,80029,288451,079May 20 06:02 PM
Ek John FrederickChief Financial OfficerMay 19Sale10.461,64817,238267,201May 20 06:00 PM
Stier EricSVP & General CounselMay 19Sale10.461,56616,380300,289May 20 05:59 PM
Winkler Sarah HollisVP, Human ResourcesMay 19Sale10.466616,914127,011May 20 05:57 PM
Gleeson MichaelSVP, Corp. AccountsMay 19Sale10.461,64817,238435,942May 20 05:56 PM
Gleeson MichaelSVP, Corp. AccountsMay 07Option Exercise6.4956,816368,736466,308May 08 05:07 PM
Mitchell Brian AndrewSVP, OperationsMay 05Sale13.497039,483242,960May 06 05:29 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesMay 05Sale13.492363,184178,112May 06 05:27 PM
Mitchell Brian AndrewSVP, OperationsMay 01Sale12.444,00049,760243,663May 04 05:10 PM
FAULKNER DARYLDirectorApr 29Option Exercise6.0014,45086,700120,238May 01 06:08 PM
Harkins Michael JohnSVP, SalesApr 29Sale11.644,12448,003132,126May 01 06:12 PM
Jensen TylerSVP, Engineering and Tech DevApr 29Sale11.648309,661216,694May 01 06:06 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesApr 29Sale11.641681,956178,348May 01 06:05 PM
Winkler Sarah HollisVP, Human ResourcesApr 29Sale11.647268,451127,672May 01 06:02 PM
Mitchell Brian AndrewSVP, OperationsApr 20Sale8.008,00064,000247,663Apr 21 05:19 PM
Mitchell Brian AndrewSVP, OperationsApr 01Sale3.992,0007,980255,663Apr 03 05:10 PM
OBOYLE KEVIN CDirectorMar 06Buy4.5310,80048,924103,550Mar 09 11:22 AM
Fox JamesDirectorMar 06Buy5.509,00049,50081,085Mar 10 11:44 AM
Kagnoff MichaelDirectorMar 04Buy4.6110,00046,100118,216Mar 05 11:44 AM
Mitchell Brian AndrewSVP, OperationsMar 02Sale3.502,0007,000257,663Mar 03 05:28 PM
Mitchell Brian AndrewSVP, OperationsFeb 27Sale3.511,9876,974259,663Feb 28 05:48 PM
Mendel ScottInterim President & CEOFeb 27Sale3.512,6599,333547,111Feb 28 05:50 PM
Ek John FrederickChief Financial OfficerFeb 27Sale3.511,0403,650268,849Feb 28 05:44 PM
Gleeson MichaelSVP, Corp. AccountsFeb 27Sale3.511,9967,006409,492Feb 28 05:46 PM
Jensen TylerSVP, Engineering and Tech DevFeb 27Sale3.519733,415217,524Feb 28 05:47 PM
Stier EricSVP & General CounselFeb 27Sale3.511,8066,339301,855Feb 28 05:44 PM
Mendel ScottInterim President & CEOFeb 25Sale3.811,4025,342549,770Feb 27 08:54 PM
Mitchell Brian AndrewSVP, OperationsFeb 25Sale3.81232884261,650Feb 27 08:53 PM
Ek John FrederickChief Financial OfficerFeb 25Sale3.815161,966269,889Feb 27 08:50 PM
Stier EricSVP & General CounselFeb 25Sale3.819853,753303,661Feb 27 08:56 PM
Jensen TylerSVP, Engineering and Tech DevFeb 25Sale3.813811,452218,497Feb 27 08:58 PM
Gleeson MichaelSVP, Corp. AccountsFeb 25Sale3.811,0534,012411,488Feb 27 08:59 PM
Gleeson MichaelSVP, Corp. AccountsFeb 20Sale3.809,70136,864326,291Feb 21 05:26 PM
Jensen TylerSVP, Engineering and Tech DevFeb 20Sale3.806,31824,008128,878Feb 21 05:19 PM
Mendel ScottInterim President & CEOFeb 20Sale3.8014,53655,237326,172Feb 21 05:17 PM
Stier EricSVP & General CounselFeb 20Sale3.809,34835,522225,896Feb 21 05:16 PM
Ek John FrederickChief Financial OfficerFeb 20Sale3.808,84833,622165,405Feb 21 05:12 PM
Mitchell Brian AndrewSVP, OperationsFeb 20Sale3.808,15530,989194,382Feb 21 05:09 PM
Winkler Sarah HollisVP, Human ResourcesFeb 20Sale3.803,38712,87153,398Feb 21 05:08 PM
Mitchell Brian AndrewSVP, OperationsFeb 04Sale5.407804,212202,537Feb 05 05:49 PM
Mitchell Brian AndrewSVP, OperationsFeb 03Sale5.412,00010,820203,317Feb 04 06:05 PM
Winkler Sarah HollisVP, Human ResourcesJan 28Sale5.448894,83656,785Jan 30 05:13 PM
Mitchell Brian AndrewSVP, OperationsJan 23Option Exercise0.0011,5630210,310Jan 23 06:40 PM
Stier EricSVP & General CounselJan 23Option Exercise0.0010,7440239,880Jan 23 06:45 PM
MASSARANY HANYPresident and CEOJan 23Option Exercise0.0075,0490851,094Jan 23 06:32 PM
Mendel ScottChief Operating OfficerJan 23Option Exercise0.0017,6970348,360Jan 23 06:34 PM
Gleeson MichaelSVP, Corp. AccountsJan 23Option Exercise0.0011,5630340,980Jan 23 06:39 PM
Jensen TylerSVP, Engineering and Tech DevJan 23Option Exercise0.006,8970138,199Jan 23 07:30 PM
Mendel ScottChief Operating OfficerJan 23Sale4.927,65237,648340,708Jan 23 06:34 PM
MASSARANY HANYPresident and CEOJan 23Sale4.9028,920141,708822,174Jan 23 06:32 PM
Stier EricSVP & General CounselJan 23Sale4.934,63622,855235,244Jan 23 06:45 PM
Mitchell Brian AndrewSVP, OperationsJan 23Sale4.934,99324,615205,317Jan 23 06:40 PM
Gleeson MichaelSVP, Corp. AccountsJan 23Sale4.934,98824,591335,992Jan 23 06:39 PM
Jensen TylerSVP, Engineering and Tech DevJan 23Sale4.913,00314,745135,196Jan 23 07:30 PM
Winkler Sarah HollisVP, Human ResourcesJan 21Option Exercise0.002,486058,778Jan 23 06:49 PM
Ek John FrederickChief Financial OfficerJan 21Option Exercise0.006,2160177,006Jan 23 06:54 PM
Winkler Sarah HollisVP, Human ResourcesJan 21Sale4.801,1045,29957,674Jan 23 06:49 PM
Ek John FrederickChief Financial OfficerJan 21Sale4.802,75313,214174,253Jan 23 06:54 PM
Mitchell Brian AndrewSVP, OperationsJan 13Sale5.052,00010,100198,747Jan 14 04:50 PM
Gleeson MichaelSVP, Corp. AccountsNov 26Sale5.6020,099112,554329,417Nov 27 06:13 PM
Mitchell Brian AndrewSVP, OperationsNov 25Sale5.431,95910,637200,747Nov 26 04:47 PM
Gleeson MichaelSVP, Corp. AccountsNov 25Sale5.432,72814,813349,516Nov 26 04:50 PM
Stier EricSVP & General CounselNov 25Sale5.432,52213,694229,136Nov 26 04:51 PM
Jensen TylerSVP, Engineering and Tech DevNov 25Sale5.431,1366,168131,302Nov 26 04:54 PM
Ek John FrederickChief Financial OfficerNov 25Sale5.431,4207,711170,790Nov 26 04:57 PM
Mendel ScottChief Operating OfficerNov 25Sale5.435,20628,269330,663Nov 26 04:59 PM
MASSARANY HANYPresident and CEONov 25Sale5.4316,42389,177776,045Nov 26 05:02 PM
McNally James B.SVP, Marketing and Bus. Dev.Nov 25Sale5.432,28812,424252,983Nov 26 05:05 PM
Stier EricSVP & General CounselNov 20Sale5.551,6339,063231,658Nov 21 05:07 PM
Jensen TylerSVP, Engineering and Tech DevNov 20Sale5.553061,698132,438Nov 21 05:00 PM
MASSARANY HANYPresident and CEONov 20Sale5.557,74442,979792,468Nov 21 04:54 PM
Mendel ScottChief Operating OfficerNov 20Sale5.552,70114,991335,869Nov 21 04:51 PM
Gleeson MichaelSVP, Corp. AccountsNov 20Sale5.551,7469,690352,244Nov 21 04:48 PM
Ek John FrederickChief Financial OfficerNov 20Sale5.554892,714172,210Nov 21 04:46 PM
Mitchell Brian AndrewSVP, OperationsNov 18Sale5.534402,433202,706Nov 19 04:49 PM
Winkler Sarah HollisVP, Human ResourcesNov 12Sale5.625,50030,91056,292Nov 12 05:22 PM
McNally James B.SVP, Marketing and Bus. Dev.Nov 05Sale5.689385,328255,271Nov 06 05:32 PM
Mitchell Brian AndrewSVP, OperationsNov 05Sale5.686603,749203,146Nov 06 05:30 PM
Winkler Sarah HollisVP, Human ResourcesOct 30Sale5.883,20818,86361,792Nov 01 04:34 PM